Dr Alice Freebairn
BSc, MBBS, MRCP, FRCR, FRCP, CCST
I graduated from King's College London and subsequently worked in Reading at the Royal Berkshire Hospital. I then moved to the Wessex rotation where I specialised in Oncology.
I am one of the training directors for the Foundation Program for Doctors at the Royal Berkshire Hospital, and am thus supporting young doctors as they start their career. I am an enhanced Appraiser for fellow Consultants and until October 2017 I was the chair of the Royal Berkshire Hospital Consultants' Committee. I am a member of the Thames Valley Head and Neck cancer group and am the oncology lead for the current MacMillan project in the Thames Valley.
I have taken part in national bowel cancer clinical trials such as the SCOT trial, looking at the length of chemotherapy needed in bowel cancer. I have also taken part in the COIN trial looking at the best duration of palliative chemotherapy for patients with bowel cancer and the Add Aspirin trial, which is currently ongoing.
In 2003 I helped set up the skin cancer MDT at the Royal Berkshire Hospital, Reading, with plastic surgeons and dermatologists working with the Oncology team. I am an integral member of the Oxford/reading head and neck cancer Multi Disciplinary Team and the Reading colorectal MDT.
Some of the principal treatments carried out by Dr Alice Freebairn at Spire include:
General surgery: Colorectal Surgery
Oncology: Skin cancer, Head and Neck cancer, Colorectal cancer
Spire Dunedin Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
BSc. / King's College London / 1992
Bachelor of Medicine
Member of the Royal College of Physicians
Fellow of the Royal College of Radiologists
Consultant Clinical Oncologist, Royal Berkshire Hospital, Reading, Berkshire